Pharma Inhouse ApS: Financial statements 2022
CVR: 41073098
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma Inhouse ApS (CVR 41073098) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 519,643 and a net result of DKK -24,998 compared with DKK -87,405 the year before. That is a decrease of 44.4% compared with the year before. Equity in the 2022 report amounted to DKK 106,323. The solvency ratio was 36.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 519,643
- Profit/Loss
- DKK -24,998
- Equity
- DKK 106,323
- Total Assets
- DKK 289,128
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 520K | -25K | 106K | 1 |
| 2021 | - | 935K | -87K | 131K | 1 |
| 2020 | - | 1.5M | 292K | 332K | 1 |
Official annual report
Keep an eye on Pharma Inhouse ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma Inhouse ApS has published its annual report for 2021. Gross profit came to DKK 934,621, and the net result was DKK -87,405.
About Pharma Inhouse ApS
Pharma Inhouse ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2020. The company has been dissolved on 28 June 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 628,581 and a net result of DKK -68,723 compared with DKK -24,998 the year before. Equity in the 2023 report amounted to DKK -28,400.